Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Assets (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Return on Assets for 4 consecutive years, with 0.22% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 13.0% to 0.22% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.22% through Dec 2025, up 13.0% year-over-year, with the annual reading at 0.2% for FY2025, 0.0% changed from the prior year.
  • Return on Assets for Q4 2025 was 0.22% at Day One Biopharmaceuticals, up from 0.29% in the prior quarter.
  • The five-year high for Return on Assets was 0.18% in Q2 2025, with the low at 0.76% in Q2 2024.
  • Average Return on Assets over 4 years is 0.4%, with a median of 0.39% recorded in 2022.
  • The sharpest move saw Return on Assets crashed -33bps in 2024, then soared 58bps in 2025.
  • Over 4 years, Return on Assets stood at 0.39% in 2022, then fell by -23bps to 0.48% in 2023, then grew by 28bps to 0.35% in 2024, then surged by 37bps to 0.22% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.22%, 0.29%, and 0.18% for Q4 2025, Q3 2025, and Q2 2025 respectively.